3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Neoplasms
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Hemangiosarcoma
1
HER2-positive Breast Cancer
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma
1
Interventions
Specimen Handling
7
pembrolizumab
6
Cisplatin
6
Magnetic Resonance Spectroscopy
4
Human Papillomavirus DNA Tests
4
Colposcopy
4
Paclitaxel
3
Nivolumab
3
Fulvestrant
3
Carboplatin
3
Bevacizumab
3
palbociclib
2
lenvatinib
2
Surveys and Questionnaires
2
Radiotherapy, Intensity-Modulated
2
Radiation Dose Hypofractionation
2
Radiation
2
Platinum
2
Magnetic Resonance Imaging
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Congresses as Topic
2
Brachytherapy
2
Biopsy
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
1,2-diaminocyclohexaneplatinum II citrate
2
ulixertinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
tucatinib
×
30 days
×
Clear all
No trials found.